SCHOTT Pharma AG & Co. KGaA (1SXP) — Cash Flow Quality Index
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow Quality Index of 2.24x as of September 2024. Operating cash flow of €75.97 Million exceeds net income of €33.97 Million, indicating high earnings quality where cash backs reported profits. Explore 1SXP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SCHOTT Pharma AG & Co. KGaA Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SCHOTT Pharma AG & Co. KGaA (1SXP) cash conversion ratio.
Annual Cash Flow Quality Index for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year earnings quality comparison for SCHOTT Pharma AG & Co. KGaA.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.51x | €225.33 Million | €149.69 Million | ▲ +25.8% |
| 2023 | 1.20x | €181.65 Million | €151.84 Million | ▼ -17.6% |
| 2022 | 1.45x | €182.12 Million | €125.38 Million | ▲ +10.7% |
| 2021 | 1.31x | €132.21 Million | €100.75 Million | ▼ -2.6% |
| 2020 | 1.35x | €104.40 Million | €77.48 Million | — |